Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 371

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 371
---
| Operating lease liabilities, non-current                             |     |             |      699,107 |   |     |               |    1,575,499 |   |
| Total operating lease liabilities                                    |     | $           |    1,575,499 |   |     | $             |    2,344,591 |   |
| Weighted-average remaining lease term of operating leases (in years) |     |             |         1.75 |   |     |               |         2.75 |   |
| Weighted-average discount rate for operating leases                  |     |             |         9.60 | % |     |               |         9.60 | % |

F-46

The following table reconciles the undiscounted future minimum lease
payments under the non-cancelable operating lease with terms of more than to the total operating lease liabilities recognized
on the Company’s balance sheet as of December 31, 2024:

Maturity of the Company’s lease liabilities as of December 31, 2024 is as follows:

| 2025                    |     | $ |   990,055 |   |
| 2026                    |     |   |   726,394 |   |
| Total lease payments    |     |   | 1,716,449 |   |
| Less: imputed interest  |     |   |  (140,950 | ) |
| Total lease liabilities |     | $ | 1,575,499 |   |

NOTE 8 – STOCKHOLDERS’ DEFICIT Successor Series A Convertible Preferred Stock The Company designated 12,580shares of its authorized preferred stock as the Series A Preferred Stock and the rights, preferences and privileges of the Series A Preferred Stock are summarized below. Each share of Series A Preferred Stock has a stated value of $ 1,000per share and, when issued, the Series A Preferred Stock was fully paid and non-assessable. The Series A Preferred Stock, ranks senior to all other Company capital stock unless required holder votes are obtained to create a class of stock senior to Series A Preferred Stock. The requisite holders of Series A Preferred Stock consented to the issuance of the Series C Preferred Stock described below, which ranks senior to the Series A Preferred Stock and Series B Preferred Stock. Dividend and Participation Rights:The holders of Series A Preferred Stock will be entitled to dividends, on an as-if converted basis, equal to and in the same form as dividends